These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 23106201)
21. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)]. Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443 [TBL] [Abstract][Full Text] [Related]
30. Intrauterine device developments. Netw Res Triangle Park N C; 1984; 5(4):4-6. PubMed ID: 12313225 [TBL] [Abstract][Full Text] [Related]
31. [Our experience with intrauterine devices (IUD) for birth control]. Vidal JJ; Flores F; López de Medina R; Aisa E; Villar JM Acta Obstet Ginecol Hisp Lusit; 1980 Feb; 28(2):87-94. PubMed ID: 7395474 [TBL] [Abstract][Full Text] [Related]
32. User characteristics, experiences and continuation rates of copper intrauterine device use in a cohort of Australian women. Bateson D; Harvey C; Trinh L; Stewart M; Black KI Aust N Z J Obstet Gynaecol; 2016 Dec; 56(6):655-661. PubMed ID: 27704541 [TBL] [Abstract][Full Text] [Related]
33. Association of Anticipated Insertional Pain With Intrauterine Device Initiation. Narayan A; Sheeder J; Guiahi M J Adolesc Health; 2018 Jul; 63(1):37-42. PubMed ID: 30060855 [TBL] [Abstract][Full Text] [Related]
34. Levonorgestrel Intrauterine Device Use in Overweight and Obese Women. Saito-Tom LY; Soon RA; Harris SC; Salcedo J; Kaneshiro BE Hawaii J Med Public Health; 2015 Nov; 74(11):369-74. PubMed ID: 26568900 [TBL] [Abstract][Full Text] [Related]
35. Pelvic inflammatory disease among women using copper IUDs, Progestasert, oral contraceptive pills or vaginal contraceptive pills: a 4-year prospective investigation. Larsson B; Rodau S; Patek E Contracept Deliv Syst; 1981 Jul; 2(3):237-42. PubMed ID: 12278910 [TBL] [Abstract][Full Text] [Related]
36. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development. Shaamash AH; Sayed GH; Hussien MM; Shaaban MM Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660 [TBL] [Abstract][Full Text] [Related]
37. Failure to insert a levonorgestrel-releasing intrauterine system: a survey based on self-reports by Israeli gynecologists. Ber A; Seidman DS Isr Med Assoc J; 2013 Mar; 15(3):163-5. PubMed ID: 23662379 [TBL] [Abstract][Full Text] [Related]
38. [The effect of intrauterine contraceptive devices on the endometrium]. Sheppard BL; Bonnar J Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565 [TBL] [Abstract][Full Text] [Related]
39. Postpartum insertion of modified intrauterine devices. Cole LP; Edelman DA; Potts DM; Wheeler RG; Laufe LE J Reprod Med; 1984 Sep; 29(9):677-82. PubMed ID: 6387112 [TBL] [Abstract][Full Text] [Related]